Results 91 to 100 of about 23,277 (221)

From gene regulation to membrane excitability: A new role for thyroid hormone in skeletal muscle

The Journal of Physiology, EarlyView.
Eric N. Jimenez‐Vazquez, David K. Jones   +1 more
wiley   +1 more source

Repercussions of Diagnostic Delay in Rare Diseases

Journal of Genetic Counseling, Volume 35, Issue 4, August 2026.
ABSTRACT Rare diseases (RDs) are often subject to diagnostic delays due to their low prevalence, clinical variability, and limited professional awareness. This scoping review aimed to map the literature on these delays, examining their clinical, emotional, and socioeconomic consequences.
Luisa Rezende Batista, Luiza Fernandes Valente, Fernando Spina, Davi Said Gonçalves Celso, Israel Gomy, Christiane Mariotini‐Moura   +5 more
wiley   +1 more source

Disorders of carbohydrate metabolism and their relationship with the prevalence of cancer in patients with acromegaly – authors’ own observations [PDF]

, 2016
Background . Acromegaly is a rare chronic disease with an excessive secretion of growth hormone, which leads to characteristic changes in appearance, organ and metabolic complications and neoplasms, which are a significant cause of shortened survival ...
Maria Kurowska, Anna Oszywa-Chabros, Oszywa-Chabros, Anna, Malicka, Joanna, Marta Dudzińska, Agata Smoleń, Jerzy S. Tarach, Dudzińska, Marta, Tarach, Jerzy, Joanna Elżbieta Malicka, Kurowska, Maria, Smoleń, Agata   +11 more
core   +2 more sources

Assessment of Serum B-Arestin Level in Acromegaly Patients with Diabetes Mellitus

Diyala Journal of Medicine
Background: Acromegaly is a rare endocrine disorder, with an annual incidence of 4 cases per million and a prevalence of 40 cases per million. The condition results from a pituitary adenoma that secretes growth hormone.
Hiba Ghassan Rajab, Shatha Mj Al-Khateeb, Abbas M. Rahmah   +2 more
doaj   +1 more source

Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study

JBMR Plus, 2019
Long‐standing growth hormone (GH) excess causes the skeletal clinical signs of acromegaly with typical changes in bone geometry, including increased cortical bone thickness (CBT).
Kristin Godang, Tove Lekva, Kjersti Ringvoll Normann, Nicoleta Cristina Olarescu, Kristin Astrid Berland Øystese, Anders Kolnes, Thor Ueland, Jens Bollerslev, Ansgar Heck   +8 more
doaj   +1 more source

Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study

, 2002
Acromegaly is frequently associated with the presence of thyroid disorders, however the exact prevalence is still controversial. An Italian multicenter study was performed on 258 patients with active acromegaly (high levels of IGF-I and lack of ...
E. Martino, L. Manetti, M. Arosio, G. Faglia, COLAO, ANNAMARIA, F. Camanni, Acromegaly Study Group of the Italian Society of Endocrinology, A. Liuzzi, A. M. Colao, G. Lombardi, S. Mariotti, LOMBARDI, GAETANO, M. Gasperi, R. Baldelli, S. Porretti   +14 more
core   +1 more source

Prevalence of Hypercementosis in Radiographic Studies: A Systematic Review and Meta‐Analysis With Clinical Implications for Endodontic Assessment

International Endodontic Journal, Volume 59, Issue 8, Page 1537-1556, August 2026.
ABSTRACT Background Hypercementosis is a non‐neoplastic condition characterized by excessive cementum deposition along the root surface, resulting in altered apical morphology. Although often asymptomatic and detected incidentally on radiographs, changes in apical contour may influence anatomical complexity in endodontic treatment.
Carlos Segura‐Raya, Víctor Diaz‐Flores, Milagros Martín‐Jiménez, Juan J. Segura‐Egea   +3 more
wiley   +1 more source

Current treatment of Acromegaly

, 2019
Acromegaly is a rare endocrine disordered, cause by excessive production of Growth Hormone usually by pituitary adenoma. The most common finding is the enlargement of the extremities hence the name “acromegaly”.
Kounnas, Ioannis
core  

Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance

, 2017
Introduction: Somatostatin (SST) receptor ligands (SRL), in particular those of first generation (Octreotide and Lanreotide), are widely used in medical treatment of acromegaly, but they assure biochemical control of disease (and the possibility of an ...
Paragliola, Rosa Maria, Corsello, Salvatore Maria   +1 more
core   +1 more source

A Teenage Guitarist's Swollen Fingers

JEADV Clinical Practice, Volume 5, Issue 3, Page 1026-1028, September 2026.
Maho Matsuo, Hiroaki Iwata
wiley   +1 more source